Vadodara News Flash

Thymidine Kinase 2 Deficiency Market Insights, Epidemiology, and Market Forecast-2030

 Breaking News
  • No posts were found

Thymidine Kinase 2 Deficiency Market Insights, Epidemiology, and Market Forecast-2030

March 24
17:51 2020
Thymidine Kinase 2 Deficiency Market Insights, Epidemiology, and Market Forecast-2030

(Albany, US) DelveInsight has launched a new report on Thymidine Kinase 2 Deficiency Market Insights, Epidemiology and Market Forecast-2030

DelveInsight’s “Thymidine Kinase 2 Deficiency Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Thymidine Kinase 2 Deficiency , historical and forecasted epidemiology as well as the Thymidine Kinase 2 Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

The Thymidine Kinase 2 Deficiency market report provides current treatment practices, emerging drugs, Thymidine Kinase 2 Deficiency (TK2D) market share of the individual therapies, current and forecasted Thymidine Kinase 2 Deficiency (TK2D) market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Thymidine Kinase 2 Deficiency (TK2D) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.

Thymidine kinase 2 deficiency (TK2d) is a sporadic genetic disorder that results in mitochondrial dysfunction, leading to inadequate energy production in cells. It was first diagnosed in children in 2001 whereas improved genetic testing led to the discovery of an
adult form of TK2d in 2013. Common symptoms of TK2d are muscle weakness that gets worse over time, low muscle tone (hypotonia, also called floppy baby syndrome), trouble breathing, problems chewing and swallowing, loss of motor skills (like crawling, walking, balancing, and grabbing), poor reflexes, neurological effects, such as seizures or altered brain activity and function, slowed mental development, hearing loss, ptosis, inability to move the eyes and eyebrows, etc.

 

 

Request for :- Thymidine Kinase 2 Deficiency free sample page

 

Thymidine Kinase 2 Deficiency Epidemiology

The Thymidine Kinase 2 Deficiency (TK2D) epidemiology division provide insights about historical and current Thymidine Kinase 2 Deficiency (TK2D) patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

 

Report Key facts:- 

1. As per study by Domínguez-González,C.et al. (2019), The late-onset is the less frequent form of presentation of the TK2 deficiency and its natural history is not well known. Patients with late onset TK2 deficiency have a consistent and recognizable clinical phenotype and a poor prognosis, due to the high risk of early and progressive respiratory insufficiency.

2. As per the study titled “TK2-Related Mitochondrial DNA Maintenance Defect, Myopathic Form”, conducted by Wang et al. (2018), the disorder appears to be rare, with approximately 107 affected individuals with a molecularly confirmed diagnosis.

 

“As per the study titled “Retrospective natural history of thymidine kinase 2 deficiency”, conducted by Garone et al. (2017), 92 patients with genetically confirmed diagnoses of TK2 deficiency were identified in which 67 were from the literature review and 25 were from unreported cases”

 

Table of Content

1. Key Insights

2. Executive Summary of Thymidine Kinase 2 Deficiency (TK2D)

3. Competitive Intelligence Analysis for Thymidine Kinase 2 Deficiency (TK2D)

4. Thymidine Kinase 2 Deficiency (TK2D) : Market Overview at a Glance

4.1. Thymidine Kinase 2 Deficiency (TK2D) Total Market Share (%) Distribution in 2017

4.2. Thymidine Kinase 2 Deficiency (TK2D) Total Market Share (%) Distribution in 2030

5. Thymidine Kinase 2 Deficiency (TK2D) : Disease Background and Overview 

6. Patient Journey

7. Thymidine Kinase 2 Deficiency (TK2D) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

8.1. Thymidine Kinase 2 Deficiency (TK2D) Treatment and Management

8.2. Thymidine Kinase 2 Deficiency (TK2D) Treatment Algorithm 

9. Unmet Needs

10. Key Endpoints of Thymidine Kinase 2 Deficiency (TK2D) Treatment

11. Marketed Products

12. Emerging Therapies

13. Thymidine Kinase 2 Deficiency (TK2D) : Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

15.1. United States: Market Size

16. Access and Reimbursement Overview of Thymidine Kinase 2 Deficiency (TK2D)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

20.1. Bibliography

20.2. Report Methodology

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

 

Why should you buy this report here ?

  • The report will help in developing business strategies by understanding trends shaping and driving the Thymidine Kinase 2 Deficiency (TK2D) market
  • To understand the future market competition in the Thymidine Kinase 2 Deficiency (TK2D) market and Insightful review of the key market drivers and barriers
  • Organize sales and marketing efforts by identifying the best opportunities for Thymidine Kinase 2 Deficiency (TK2D) in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
  • Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
  • Organize sales and marketing efforts by identifying the best opportunities for Thymidine Kinase 2 Deficiency (TK2D) market
  • To understand the future market competition in the Thymidine Kinase 2 Deficiency (TK2D) market

Related Reports:-

1. Thymidine Kinase 2 Deficiency (TK2D) – Epidemiology Forecast to 2030

2. Thymidine Kinase 2 Deficiency (TK2D) – Pipeline Insights, 2020

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

Related Articles